In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole and Abciximab) may increase the risk of bleeding if administered prior to, during, or after Activase therapy.
<heparin, effect, Activase>, <vitamin K antagonists, effect, Activase>, <acetylsalicylic acid, int, Activase>, <dipyridamole, effect, Activase>, <Abciximab, effect, Activase>